GSKCONS

The Promoter along with PAC has submitted to the Exchange a copy of Annual Disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares and Takeovers), Regulations, 2011 as on March 31, 2019

The Promoter has submitted to the Exchange a copy of Annual Disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares and Takeovers), Regulations, 2011 as on March 31, 2019.

Horlicks Limited has submitted to the Exchange a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

GlaxoSmithKline Pte Ltd has submitted to the Exchange a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Horlicks Limited has submitted to the Exchange vide letter dated April 1, 2016 a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Horlicks Limited has submitted to the Exchange vide letter dated April 02, 2015 a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

GlaxoSmithKline Pte. Limited has submitted to the Exchange vide letter dated April 07, 2015 a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Arisaig Partners (Asia) Pte. Ltd. has submitted to the Exchange vide letter dated June 13, 2013 a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 along with a copy of disclosure pursuant to Regulations 13(3) and 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.

GlaxoSmithKline Pte Ltd has submitted to the Exchange, vide letter dated February 13, 2013 a copy of Disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Glaxosmithkline Consumer Healthcare Limited has submitted to the Exchange a copy of Recommendations of the Committee of Independent Director (IDC) on the Open Offer to the Shareholders of Company under Regulation 26(7) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Glaxosmithkline Consumer Healthcare Limited has submitted to the Exchange a copy of annual declaration/ disclosure forms as received from employees of the Company under SEBI (Prohibition of Insider Trading) Regulations, 1992.

Glaxosmithkline Consumer Healthcare Limited has submitted to the Exchange a copy of disclosure as per SEBI (Prohibition of Insider Trading) Regulations, 1992.

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange regarding an information as per Regulation 13 (3) & (6) of the SEBI (Prohibition of Insider Trading Regulations)1992 in accordance with the intimation received from HDFC Trustee Company Limited on April 12, 2010. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Gsk_Reg_16042010.zip target=NEW> For more details click here.</a>

Glaxosmithkline Consumer Healthcare Limited has submitted to the Exchange a copy of annual declaration / disclosure form as received from employees of the Company (details as per annexure) under SEBI (Prohibition of Insider Trading) Regulations, 1992.The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/GSK_disc_03022010.zip target=NEW> For more details click here.</a>

Glaxosmithkline Consumer Healthcare Limited has submitted the Exchange a copy of annual declaration / disclosure form as received from employees of the Company (details as per annexure) under SEBI (Prohibition of Insider Trading) Regulations, 1992.The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/gsk_DIS_22012010.ZIP target=NEW> For more details click here.</a>

Glaxosmithkline Consumer Healthcare Limited has submitted to the Exchange information as per Regulation 13(3) and 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992. The details of the same shall be available on the NSE website (http://www.nseindia.com) under Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/gskcons_reg_23122009.zip target=NEW> For more details click here.</a>

Glaxosmithkline Consumer Healthcare Limited has submitted to the Exchange a copy of annual declaration / disclosure form as received from employees of the Company under SEBI (Prohibition of Insider Trading) Regulations, 1992. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Glaxo_Dis_21012009.zip target=NEW> For more details click here.</a>

Glaxosmithkline Consumer Healthcare Limited has submitted to the Exchange a copy of annual declaration / disclosure form as received from employees of the Company under SEBI (Prohibition of Insider Trading) Regulations, 1992. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/GSKCons_Dis_21022009.zip target=NEW> For more details click here.</a>

Glaxosmithkline Consumer Healthcare Limited has submitted to the Exchange a copy of annual declaration / disclosure form as received from employees of the Company. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/glaxo_reg_28012008.zip target=NEW> For more details click here.</a>

Glaxosmithkline Consumer Healthcare Limited has submitted to the Exchange a copy of annual declaration / disclosure forms as per letter dated February 08, 2007. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/glaxo_reg1_130207.zip target=NEW> For more details click here.</a>

Glaxosmithkline Consumer Healthcare Limited has submitted to the Exchange a copy of annual declaration / disclosure forms as per letter dated February 07, 2007. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/GSKCONS_090207.zip target=NEW> For more details click here.</a>

Glaxosmithkline Consumer Healthcare Limited has submitted to the Exchange a copy of annual declaration / disclosure form as received from the following: (i) Name of Declaring Person - Nitin Mathur (ii) Designation of Declaring Person - Manager - Finance. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/GSK_ITREG_07022007.zip target=NEW> For more details click here.</a>

Glaxosmithkline Consumer Healthcare Limited has submitted to the Exchange a copy of annual declaration / disclosure forms as per letter dated January 12, 2007. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/glaxocons_dec-170107.zip target=NEW> For more details click here.</a>

Glaxosmithkline Consumer Healthcare Limited has submitted to the Exchange a copy of annual declaration / disclosure forms as per letter dated January 15, 2007. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/glaxo_dec_170107.zip target=NEW> For more details click here.</a>

Glaxosmithkline Consumer Healthcare Limited has submitted to the Exchange a copy of annual declaration / disclosure forms as per letter dated January 08,2007. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/glaxo_annualdec_120107.zip target=NEW> For more details click here.</a>

Glaxosmithkline Consumer Healthcare Limited has submitted to the Exchange a copy of annual declaration / disclosure forms as per letter dated January 10 ,2007. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/gsk_Annual_120107.zip target=NEW> For more details click here.</a>

Glaxosmithkline Consumer Healthcare Limited has submitted to the Exchange a copy of annual declaration / disclosure forms as per letter dated January 09,2007. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/gskchl_declaration_120107.zip target=NEW> For more details click here.</a>

Glaxosmithkline Consumer Healthcare Limited has submitted to the Exchange a copy of annual declaration / disclosure forms as per letter dated January 03,2007. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/GSK_Dis_12012007.zip target=NEW> For more details click here.</a>

Glaxosmithkline Consumer Healthcare Limited has submitted to the Exchange as per letter dated January 05, 2007 a copy of annual declaration/ disclosure forms as received from the Directors of the Company. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server.<a href=/content/corporate/GSK_Dis_09012007.zip target=NEW> For more details click here.</a>

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that HDFC Mutual Fund under its schemes has acquired the shares as follows: HDFC Prudence Fund has acquired 200,000 shares aggregating to 0.47% of the total paid up capital of Glaxosmithkline Consumer Healthcare Limited on June 22, 2006. The mode of acquisition is through Market Purchase and the shareholding of HDFC Mutual Fund under its schemes after the said acquisition is 21,63,278 shares aggregating to 5.14% as follows:- 1) HDFC Prudence Fund total shareholding is 6,84,523 shares aggregating to 1.63%; 2) HDFC Long Term E

HDFC Asset Management Company Limited has informed the Exchange that HDFC Mutual Fund under its schemes has acquired the shares as follows: HDFC Prudence Fund has acquired 200,000 shares aggregating to 0.47% of the total paid up capital of Glaxosmithkline Consumer Healthcare Limited on June 22, 2006. The mode of acquisition is through Market Purchase and the shareholding of HDFC Mutual Fund under its schemes after the said acquisition is 21,63,278 shares aggregating to 5.14% as follows:- 1) HDFC Prudence Fund total shareholding is 6,84,523 shares aggregating to 1.63%; 2) HDFC Long Term Equity

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that Praveen K. Gupta, Director-Operations holds 3 shares of the company as on December 31, 2005.

Glaxosmithkline Consumer Healthcare Limited has submitted to the Exchange a copy of annual declaration/ disclosure forms as received on January 09, 2006 from the Directors of the Company. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server.

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange of the annual declaration/disclosure of details of shares held by Directors/Officers/ Employees as on December 31, 2004. The details are as follows: 1) Gautam Chakraborty, Director - Finance and IT holds Nil shares; 2) Ms. Sarmila Chakraborty, wife of Gautam Chakraborty and Ms.Rikhia Chakraborty,Daughter of Gautam Chakraborty, both hold Nil shares.

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange of the annual declaration/disclosure of details of shares held by Directors/Officers/ Employees/Dependent Family Members as on December 31, 2004. The details are as follows: 1) P Dwarakanath, Director - HR & Admn. holds Nil shares; 2) Usha Dwarakanath (Wife of P. Dwarakanath) holds Nil shares.

Glaxosmithkline Consumer Healthcare Limited has submitted to the Exchange the annual declaration / disclosure of shares of the company held by Directors/Officers/Employees as on December 31,2004.The details of the same are as follows : 1) Mr. Nicholas John Massey, Managing Director holds Nil shares. 2)Mr. Partha S Mukherjee, Director Legal & Corporate Affairs holds Nil shares and Minoti Mukherjee (Jt.P S Mukherjee) wife holds 646 shares. 3) Mr. David A Allen ,Director Operations holds Nil shares. 4) Mr. A S Lakshmanan, Director holds Nil shares.5)Mr.Subodh Bhargava, who has joined as Director

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that Mr. Arnab Roy Choudhury,holds Nil shares of the company.